Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis

Table 2 Laboratory results at the time of intervention (n = 127)

	CRP	Hemoglobin	Leukocytes	Thrombocytes	Bilirubin	Creatinine	GGT	AP	AST	ALT	PCHE	Lipase
	(mg/dL)	(g/dL)	(1000/μL)	(1000/μL)	(mg/dL)	(mg/dL)	(U/L)	(U/L)	(U/L)	(U/L)	(U/L)	(U/L)
Group I
mean ± SD	3.9 ± 6.1	12.2 ± 1.8	7.9 ± 4.5	258.5 ± 151.5	4.0 ± 7.2	1.1 ± 0.7	507.6 ± 766.7	374.4 ± 301.4	120.0 ± 134.6	124.0 ± 182	2161.5 ± 3580.3	196.2 ± 568.1
Group II
mean ± SD	3.9 ± 3.3	11.6 ± 2.0	7.6 ± 3.7	270.6 ± 144.0	5.1 ± 7.7	1.2 ± 1.0	430.1 ± 403.4	395.8 ± 281.6	106.8 ± 90.8	101.1 ± 110.8	576.4 ± 1144.5	226.5 ± 623.6
P	0.090	0.090	0.900	0.525	0.341	0.767	0.424	0.722	0.940	0.870	0.501	0.790

P data generated by Mann-Whitney U test. Group I: Patients without biliary candidiasis, n = 89; Group II: Patients with biliary candidiasis, n = 38. CRP: C-reactive protein; PCHE: Pseudocholinesterase; GGT: Gamma glutamyl transpeptidase; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; AP: Alkaline phosphatase.